# Analysis and Modelling of Erlotinib (Tarceva) PKPD

The analysis of the pharamacokinetic and pharmacodynamic properties is organised in notebooks. A brief overview of the notebooks' contents is given below.

## Notebook overview

- Treating Lung Cancer with Erlotinib
    - Analysis of lung cancer growth in the control group
        - [Preparation of the data](https://nbviewer.jupyter.org/github/DavAug/chi/blob/main/analysis/treating_lung_cancer/control_group_analysis/preparing_data.ipynb)
        - [Infer model parameters for each individual separately](https://nbviewer.jupyter.org/github/DavAug/chi/blob/main/analysis/treating_lung_cancer/control_group_analysis/tgi_koch_2009_model/individual_inference.ipynb)
        - [Infer fully pooled model parameters across individuals](https://nbviewer.jupyter.org/github/DavAug/chi/blob/main/analysis/treating_lung_cancer/control_group_analysis/tgi_koch_2009_model/fully_pooled_inference.ipynb)
